Published in Infect Control Hosp Epidemiol on August 01, 2000
Trial of Void With Saline Bladder Instillation | NCT03609476
Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature (2008) 4.87
Candida infections of medical devices. Clin Microbiol Rev (2004) 4.72
Genomic islands: tools of bacterial horizontal gene transfer and evolution. FEMS Microbiol Rev (2008) 3.80
Endocarditis and biofilm-associated pili of Enterococcus faecalis. J Clin Invest (2006) 3.33
Role of sentinel surveillance of candidemia: trends in species distribution and antifungal susceptibility. J Clin Microbiol (2002) 3.27
Telavancin versus vancomycin for hospital-acquired pneumonia due to gram-positive pathogens. Clin Infect Dis (2011) 3.20
Role of Enterococcus faecalis surface protein Esp in the pathogenesis of ascending urinary tract infection. Infect Immun (2001) 2.62
Genetic diversity among Enterococcus faecalis. PLoS One (2007) 2.32
Development of a host-genotype-independent counterselectable marker and a high-frequency conjugative delivery system and their use in genetic analysis of Enterococcus faecalis. Plasmid (2006) 2.26
Esp-independent biofilm formation by Enterococcus faecalis. J Bacteriol (2004) 2.20
Biofilm production by Candida species and inadequate antifungal therapy as predictors of mortality for patients with candidemia. J Clin Microbiol (2007) 1.99
Virulence effect of Enterococcus faecalis protease genes and the quorum-sensing locus fsr in Caenorhabditis elegans and mice. Infect Immun (2002) 1.96
Candida infections of the genitourinary tract. Clin Microbiol Rev (2010) 1.90
Enterococcal surface protein, Esp, enhances biofilm formation by Enterococcus faecalis. Infect Immun (2004) 1.84
The capsular polysaccharide of Enterococcus faecalis and its relationship to other polysaccharides in the cell wall. Proc Natl Acad Sci U S A (2002) 1.68
Toxin-antitoxin systems are ubiquitous and plasmid-encoded in vancomycin-resistant enterococci. Proc Natl Acad Sci U S A (2006) 1.68
A eukaryotic-type Ser/Thr kinase in Enterococcus faecalis mediates antimicrobial resistance and intestinal persistence. Proc Natl Acad Sci U S A (2007) 1.55
Staphylococcus aureus screening and decolonization in orthopaedic surgery and reduction of surgical site infections. Clin Orthop Relat Res (2013) 1.53
Bench-to-bedside review: Candida infections in the intensive care unit. Crit Care (2008) 1.49
Putative surface proteins encoded within a novel transferable locus confer a high-biofilm phenotype to Enterococcus faecalis. J Bacteriol (2006) 1.47
Two-component signal transduction in Enterococcus faecalis. J Bacteriol (2002) 1.42
The genus Hafnia: from soup to nuts. Clin Microbiol Rev (2006) 1.40
EfrAB, an ABC multidrug efflux pump in Enterococcus faecalis. Antimicrob Agents Chemother (2003) 1.35
The molecular alarmone (p)ppGpp mediates stress responses, vancomycin tolerance, and virulence in Enterococcus faecalis. J Bacteriol (2009) 1.35
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study. Antimicrob Agents Chemother (2005) 1.34
Development of a method for markerless genetic exchange in Enterococcus faecalis and its use in construction of a srtA mutant. Appl Environ Microbiol (2005) 1.34
Ventilator associated pneumonia and infection control. Ann Clin Microbiol Antimicrob (2006) 1.29
Translocation of ExsE into Chinese hamster ovary cells is required for transcriptional induction of the Pseudomonas aeruginosa type III secretion system. Infect Immun (2007) 1.26
Comparative genomic analysis of pathogenic and probiotic Enterococcus faecalis isolates, and their transcriptional responses to growth in human urine. PLoS One (2010) 1.23
In vitro activity of doripenem, a carbapenem for the treatment of challenging infections caused by gram-negative bacteria, against recent clinical isolates from the United States. Antimicrob Agents Chemother (2008) 1.21
Development and use of an efficient system for random mariner transposon mutagenesis to identify novel genetic determinants of biofilm formation in the core Enterococcus faecalis genome. Appl Environ Microbiol (2008) 1.20
Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved? Support Care Cancer (2014) 1.20
Gelatinase contributes to the pathogenesis of endocarditis caused by Enterococcus faecalis. Infect Immun (2010) 1.20
Comparative genomics of Enterococcus faecalis from healthy Norwegian infants. BMC Genomics (2009) 1.19
Management of catheter-associated urinary tract infection. Curr Opin Infect Dis (2010) 1.19
Bacteriocin production augments niche competition by enterococci in the mammalian gastrointestinal tract. Nature (2015) 1.19
Capsular polysaccharide production in Enterococcus faecalis and contribution of CpsF to capsule serospecificity. J Bacteriol (2009) 1.17
Signal transduction, quorum-sensing, and extracellular protease activity in Enterococcus faecalis biofilm formation. J Bacteriol (2004) 1.17
An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth. Infect Immun (2003) 1.16
Attributable costs of enterococcal bloodstream infections in a nonsurgical hospital cohort. Infect Control Hosp Epidemiol (2010) 1.16
The transcriptome of the nosocomial pathogen Enterococcus faecalis V583 reveals adaptive responses to growth in blood. PLoS One (2009) 1.15
Drug resistance & virulence determinants in clinical isolates of Enterococcus species. Indian J Med Res (2013) 1.15
Molecular analysis of the Enterococcus faecalis serotype 2 polysaccharide determinant. J Bacteriol (2003) 1.14
Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study. Ann Clin Microbiol Antimicrob (2004) 1.14
Functional domains of ExsA, the transcriptional activator of the Pseudomonas aeruginosa type III secretion system. J Bacteriol (2009) 1.13
The cyclic AMP-dependent catabolite repression system of Serratia marcescens mediates biofilm formation through regulation of type 1 fimbriae. Appl Environ Microbiol (2008) 1.12
Intensive care unit-acquired urinary tract infections in a regional critical care system. Crit Care (2005) 1.11
Time to blood culture positivity as a marker for catheter-related candidemia. J Clin Microbiol (2008) 1.10
Enterococcal leucine-rich repeat-containing protein involved in virulence and host inflammatory response. Infect Immun (2007) 1.09
Genetic variation and evolution of the pathogenicity island of Enterococcus faecalis. J Bacteriol (2009) 1.08
Risk factors for late-onset health care-associated bloodstream infections in patients in neonatal intensive care units. Am J Infect Control (2007) 1.08
Efficacy of parenteral nutrition supplemented with glutamine dipeptide to decrease hospital infections in critically ill surgical patients. JPEN J Parenter Enteral Nutr (2008) 1.07
Insyght: navigating amongst abundant homologues, syntenies and gene functional annotations in bacteria, it's that symbol! Nucleic Acids Res (2014) 1.07
Determinants of mortality in non-neutropenic ICU patients with candidaemia. Crit Care (2009) 1.06
Txe, an endoribonuclease of the enterococcal Axe-Txe toxin-antitoxin system, cleaves mRNA and inhibits protein synthesis. Microbiology (2010) 1.06
Laboratory diagnosis of lower respiratory tract infections: controversy and conundrums. J Clin Microbiol (2002) 1.05
Mechanism of transcriptional activation by Pseudomonas aeruginosa ExsA. J Bacteriol (2009) 1.05
Role of Klebsiella pneumoniae type 1 and type 3 fimbriae in colonizing silicone tubes implanted into the bladders of mice as a model of catheter-associated urinary tract infections. Infect Immun (2013) 1.04
Ventilator-associated tracheitis in children: does antibiotic duration matter? Clin Infect Dis (2011) 1.04
Presence of genes encoding panton-valentine leukocidin is not the primary determinant of outcome in patients with hospital-acquired pneumonia due to Staphylococcus aureus. J Clin Microbiol (2012) 1.04
Nosocomial bloodstream infection and clinical sepsis. Emerg Infect Dis (2004) 1.03
Dynamic remodeling of microbial biofilms by functionally distinct exopolysaccharides. MBio (2014) 1.03
A program for sustained improvement in preventing ventilator associated pneumonia in an intensive care setting. BMC Infect Dis (2012) 1.02
Clinician response to Candida organisms in the urine of patients attending hospital. Eur J Clin Microbiol Infect Dis (2007) 1.01
Costs and risk factors for ventilator-associated pneumonia in a Turkish university hospital's intensive care unit: a case-control study. BMC Pulm Med (2004) 1.00
Virulence factors and antibiotic susceptibility in enterococci isolated from oral mucosal and deep infections. J Oral Microbiol (2012) 0.98
Structure, function, and biology of the Enterococcus faecalis cytolysin. Toxins (Basel) (2013) 0.97
Characterization of the Ers regulon of Enterococcus faecalis. Infect Immun (2008) 0.96
Enterococcus faecalis capsular polysaccharide serotypes C and D and their contributions to host innate immune evasion. Infect Immun (2009) 0.96
Candidemia on presentation to the hospital: development and validation of a risk score. Crit Care (2009) 0.95
Modulation of bacterial Type III secretion system by a spermidine transporter dependent signaling pathway. PLoS One (2007) 0.94
Nosocomial infections in the intensive care unit: Incidence, risk factors, outcome and associated pathogens in a public tertiary teaching hospital of Eastern India. Indian J Crit Care Med (2015) 0.93
Epidemiological surveillance of bacterial nosocomial infections in the surgical intensive care unit. Mater Sociomed (2014) 0.92
Complete genome sequence of the commensal Enterococcus faecalis 62, isolated from a healthy Norwegian infant. J Bacteriol (2011) 0.92
Approach to a patient with urosepsis. J Glob Infect Dis (2009) 0.92
Antibiotic resistance of bacteria isolated from the internal organs of edible snow crabs. PLoS One (2013) 0.91
Detection of Helicobacter pylori, Enterococcus faecalis, and Pseudomonas aeruginosa in the subgingival biofilm of HIV-infected subjects undergoing HAART with chronic periodontitis. Eur J Clin Microbiol Infect Dis (2009) 0.91
Bacterial pathogens of ventilator associated pneumonia in a tertiary referral hospital. Tuberc Respir Dis (Seoul) (2012) 0.91
Staphylococcus aureus NfrA (SA0367) is a flavin mononucleotide-dependent NADPH oxidase involved in oxidative stress response. J Bacteriol (2005) 0.91
Comparative genomic analysis reveals significant enrichment of mobile genetic elements and genes encoding surface structure-proteins in hospital-associated clonal complex 2 Enterococcus faecalis. BMC Microbiol (2011) 0.91
The role of Candida albicans AP-1 protein against host derived ROS in in vivo models of infection. Virulence (2013) 0.90
A Serratia marcescens PigP homolog controls prodigiosin biosynthesis, swarming motility and hemolysis and is regulated by cAMP-CRP and HexS. PLoS One (2013) 0.90
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit. Crit Care (2010) 0.90
Increased expression of type-1 fimbriae by nonpathogenic Escherichia coli 83972 results in an increased capacity for catheter adherence and bacterial interference. J Infect Dis (2008) 0.89
The N-terminal domain of enterococcal surface protein, Esp, is sufficient for Esp-mediated biofilm enhancement in Enterococcus faecalis. J Bacteriol (2005) 0.88
IreB, a Ser/Thr kinase substrate, influences antimicrobial resistance in Enterococcus faecalis. Antimicrob Agents Chemother (2013) 0.88
A risk factor analysis of healthcare-associated fungal infections in an intensive care unit: a retrospective cohort study. BMC Infect Dis (2013) 0.87
Orientation of Pseudomonas aeruginosa ExsA monomers bound to promoter DNA and base-specific contacts with the P(exoT) promoter. J Bacteriol (2012) 0.87
Nosocomial Infections in the Intensive Care Unit Associated with Invasive Medical Devices. Curr Infect Dis Rep (2001) 0.87
A comparison of the bacteria found on the hands of 'homemakers' and neonatal intensive care unit nurses. J Hosp Infect (2003) 0.86
A murine model for catheter-associated candiduria. J Med Microbiol (2011) 0.86
micropan: an R-package for microbial pan-genomics. BMC Bioinformatics (2015) 0.86
Vancomycin and nephrotoxicity: just another myth? J Trauma Acute Care Surg (2013) 0.86
ExsA recruits RNA polymerase to an extended -10 promoter by contacting region 4.2 of sigma-70. J Bacteriol (2010) 0.86
An in vitro study on the effects of nisin on the antibacterial activities of 18 antibiotics against Enterococcus faecalis. PLoS One (2014) 0.85
A trilocus sequence typing scheme for hospital epidemiology and subspecies differentiation of an important nosocomial pathogen, Enterococcus faecalis. J Clin Microbiol (2009) 0.85
Transcriptomic and functional analysis of NaCl-induced stress in Enterococcus faecalis. PLoS One (2014) 0.84
A 10-year survey of antifungal susceptibility of candidemia isolates from intensive care unit patients in Greece. Antimicrob Agents Chemother (2008) 0.84
Assessment of candidemia-attributable mortality in critically ill patients using propensity score matching analysis. Crit Care (2012) 0.84
Predicting hospital-acquired infections by scoring system with simple parameters. PLoS One (2011) 0.84
Secular trends in nosocomial primary bloodstream infections in the United States, 1980-1989. National Nosocomial Infections Surveillance System. Am J Med (1991) 9.11
Major trends in the microbial etiology of nosocomial infection. Am J Med (1991) 8.56
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Infect Control Hosp Epidemiol (1992) 8.28
An overview of nosocomial infections, including the role of the microbiology laboratory. Clin Microbiol Rev (1993) 8.03
Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med (1999) 7.90
A case-control study of HIV seroconversion in health care workers after percutaneous exposure. Centers for Disease Control and Prevention Needlestick Surveillance Group. N Engl J Med (1997) 7.11
The efficacy of infection surveillance and control programs in preventing nosocomial infections in US hospitals. Am J Epidemiol (1985) 6.94
Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol (1992) 5.98
Strategies to Prevent and Control the Emergence and Spread of Antimicrobial-Resistant Microorganisms in Hospitals. A challenge to hospital leadership. JAMA (1996) 4.80
Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol (1991) 4.79
Surgical wound infection rates by wound class, operative procedure, and patient risk index. National Nosocomial Infections Surveillance System. Am J Med (1991) 4.72
Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999. Clin Infect Dis (2002) 4.35
Surveillance of antimicrobial use and antimicrobial resistance in United States hospitals: project ICARE phase 2. Project Intensive Care Antimicrobial Resistance Epidemiology (ICARE) hospitals. Clin Infect Dis (1999) 3.77
The nationwide nosocomial infection rate. A new need for vital statistics. Am J Epidemiol (1985) 3.70
Nosocomial infection rates in adult and pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med (1991) 3.06
Blood contacts during surgical procedures. JAMA (1991) 3.03
Percutaneous injuries during surgical procedures. JAMA (1992) 3.01
National nosocomial infections surveillance system (NNIS): description of surveillance methods. Am J Infect Control (1991) 3.00
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control (1992) 2.95
Surveillance of HIV infection and zidovudine use among health care workers after occupational exposure to HIV-infected blood. The CDC Cooperative Needlestick Surveillance Group. Ann Intern Med (1993) 2.45
Structure of a rhamnolipid from Pseudomonas aeruginosa. Arch Biochem Biophys (1965) 2.35
Resistance to imipenem among selected gram-negative bacilli in the United States. Infect Control Hosp Epidemiol (1992) 2.30
Nosocomial infections in pediatric intensive care units in the United States. National Nosocomial Infections Surveillance System. Pediatrics (1999) 2.25
Nosocomial infections in U.S. hospitals, 1975-1976: estimated frequency by selected characteristics of patients. Am J Med (1981) 2.21
Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol (1985) 2.20
Surgical site infection (SSI) rates in the United States, 1992-1998: the National Nosocomial Infections Surveillance System basic SSI risk index. Clin Infect Dis (2001) 2.10
Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol (1990) 2.06
Correlation between growth inhibition and the binding of various penicillins and cephalosporins to Staphylococcus aureus. J Bacteriol (1969) 2.01
Antimicrobial resistance in intensive care units. Clin Chest Med (1999) 1.92
Determinants of vancomycin use in adult intensive care units in 41 United States hospitals. Clin Infect Dis (1999) 1.86
Accuracy of reporting nosocomial infections in intensive-care-unit patients to the National Nosocomial Infections Surveillance System: a pilot study. Infect Control Hosp Epidemiol (1998) 1.79
Nosocomial infections in surgical patients in the United States, January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System. Infect Control Hosp Epidemiol (1993) 1.78
The effect of vancomycin and third-generation cephalosporins on prevalence of vancomycin-resistant enterococci in 126 U.S. adult intensive care units. Ann Intern Med (2001) 1.72
Ceftazidime resistance among selected nosocomial gram-negative bacilli in the United States. National Nosocomial Infections Surveillance System. J Infect Dis (1994) 1.72
Glycopeptide-intermediate Staphylococcus aureus: evaluation of a novel screening method and results of a survey of selected U.S. hospitals. J Clin Microbiol (1999) 1.68
The impact of antimicrobial-resistant, health care-associated infections on mortality in the United States. Clin Infect Dis (2008) 1.64
Ciprofloxacin resistance among nosocomial Pseudomonas aeruginosa and Staphylococcus aureus in the United States. Infect Control Hosp Epidemiol (1995) 1.64
The epidemiology of nosocomial infections caused by Klebsiella pneumoniae. Infect Control (1985) 1.60
Investigations of patients of health care workers infected with HIV. The Centers for Disease Control and Prevention database. Ann Intern Med (1995) 1.59
Ability of laboratories to detect emerging antimicrobial resistance in nosocomial pathogens: a survey of project ICARE laboratories. Diagn Microbiol Infect Dis (2000) 1.57
Serosurvey of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among hospital-based surgeons. Serosurvey Study Group. J Am Coll Surg (1995) 1.57
Nosocomial infections among neonates in high-risk nurseries in the United States. National Nosocomial Infections Surveillance System. Pediatrics (1996) 1.53
Antimicrobial resistance prevalence rates in hospital antibiograms reflect prevalence rates among pathogens associated with hospital-acquired infections. Clin Infect Dis (2001) 1.50
Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma. Bone Marrow Transplant (2008) 1.46
Kidney injury molecule-1 is an early biomarker of cadmium nephrotoxicity. Kidney Int (2007) 1.46
High-dose chemotherapy and autologous stem-cell transplantation for ovarian cancer: an autologous blood and marrow transplant registry report. Ann Intern Med (2000) 1.42
Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ (1986) 1.41
Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modeling. Intensive Care Antimicrobial Resistance Epidemiology Project and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol (1998) 1.39
Synthesis of a broth levan by a cell-bound levansucrase from Streptococcus salivarius (SS2). Arch Oral Biol (1973) 1.36
Evidence of interhospital transmission of extended-spectrum beta-lactam-resistant Klebsiella pneumoniae in the United States, 1986 to 1993. The National Nosocomial Infections Surveillance System. Infect Control Hosp Epidemiol (1997) 1.36
Reassessment of the association between Guillain-Barré syndrome and receipt of swine influenza vaccine in 1976-1977: results of a two-state study. Expert Neurology Group. Am J Epidemiol (1991) 1.32
Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hosp Epidemiol (2000) 1.22
Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control (1985) 1.20
Evolution of hospital participation in the National Nosocomial Infections Surveillance System, 1986 to 1993. Am J Infect Control (1995) 1.20
In vitro activity of meropenem and imipenem against mycobacteria: development of a daily antibiotic dosing schedule. Tuber Lung Dis (1992) 1.20
Detailed structure of a dextran from a cariogenic bacterium. Carbohydr Res (1972) 1.20
Surveillance of nosocomial infections: a fundamental ingredient for quality. Infect Control Hosp Epidemiol (1997) 1.17
Comparison of rates of nosocomial infections in neonatal intensive care units in the United States. National Nosocomial Infections Surveillance System. Am J Med (1991) 1.16
Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci. J Clin Microbiol (1995) 1.15
Hospital-acquired infections in the United States. The importance of interhospital comparisons. Infect Dis Clin North Am (1997) 1.14
In vivo studies on the uptake and binding of beta-lactam antibiotics in relation to inhibition of wall synthesis and cell death. Ann N Y Acad Sci (1974) 1.12
Antibiotic-resistant flora in nursing home patients admitted to the hospital. Arch Intern Med (1985) 1.10
Nosocomial infections in elderly patients in the United States, 1986-1990. National Nosocomial Infections Surveillance System. Am J Med (1991) 1.08